Eventide Asset Management - MEDIVATION INC ownership

Quarter-by-quarter ownership
Eventide Asset Management ownership history of MEDIVATION INC
ValueSharesWeighting
Q2 2016$9,045,000
-59.4%
150,000
-69.0%
0.55%
-55.5%
Q1 2016$22,259,000
-4.9%
484,1000.0%1.24%
+6.3%
Q4 2015$23,401,000
+17.8%
484,100
+3.6%
1.17%
+1.4%
Q3 2015$19,865,000
-16.4%
467,400
+124.5%
1.15%
-10.3%
Q2 2015$23,776,000
-11.5%
208,2000.0%1.29%
-36.4%
Q1 2015$26,872,000
+27.8%
208,200
-1.4%
2.02%
-11.9%
Q4 2014$21,028,000
-22.7%
211,100
-23.3%
2.30%
-39.6%
Q3 2014$27,219,000
+28.3%
275,3000.0%3.80%
+31.7%
Q2 2014$21,220,000
+24.6%
275,300
+4.1%
2.89%
+9.2%
Q1 2014$17,026,000
+97.9%
264,500
+96.2%
2.64%
-0.3%
Q4 2013$8,603,000134,8002.65%
Other shareholders
MEDIVATION INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,198,919$283,814,00082.63%
BB BIOTECH AG 1,274,706$164,526,0004.90%
Selkirk Management LLC 64,300$8,299,0004.61%
Opus Point Partners Management, LLC 30,747$3,969,0003.33%
Arlington Capital Management, Inc. 28,845$3,723,0002.67%
Orbimed Advisors 2,348,900$303,173,0002.59%
BENNETT LAWRENCE MANAGEMENT L L C/NY 70,900$9,151,0002.44%
HealthCor Management, L.P. 375,000$48,401,0002.31%
BENDER ROBERT & ASSOCIATES 27,084$3,496,0002.04%
Eventide Asset Management 208,200$26,872,0002.02%
View complete list of MEDIVATION INC shareholders